Anish Moonka Profile picture
Jul 26, 2021 โ€ข 18 tweets โ€ข 8 min read โ€ข Read on X
Glenmark Life Sciences (GLS) IPO notes ๐Ÿ”ฌ

Plans to take the capacity to 1762KL (currently 762KL) in the next 4 years.

Hit the 'retweet' & help us educate more investors

A thread ๐Ÿงต๐Ÿ‘‡

#IPOwithJST
1/ About the company

Developer & manufacturer of high value, non- commoditized APIs (complex & low competition) in chronic therapeutic areas: CVS, CNS, pain management & diabetes, etc

Basic details about the IPO ๐Ÿ‘‡

Note: After paying off liabilities, 150crs remain for capex.
2/ The Journey

Established the API business in FY02

Since 2015, Have not received any adverse reactions from regulators (USFDA, PMDA) in the total 38 audits & inspections & Have gone through 432 customer audits.

Filled 403 DMFs & CEP registration across markets globally.
3/ Trends that the company is betting on & what works for them

China+1: India API market growth (10% cagr projected from FY21-26) will outpace the industry: Driven by specialty API+ Strong domestic market

Highest no. of USFDA approved API facilities & % of DMFs filled
4/ Interesting facts

- 120 molecules: $142B market size
- Targetting 8 to 10 new molecules every yr (Key differentiator over time)
- 66% of sales from regulated markets
- Works with 16 of the top 20 generic cos.
- Top 7 customers: 5 to 15yrs old
5/ API Portfolio

Key products in generic API business ๐Ÿ‘‡ (Shows cost leadership in few molecules as market share is 30%+)

Strategy to mix: High value & High Volume APIs

Complex API is a future growth market: Going into the development of Peptide APIs by FY22.
6/ R&D: the secret ingredient

Spends 2-2.5% of rev every year
39 patents under the belt
213 R&D personnel in 3 dedicated facilities

Focus on cost improvements in existing products & developing newer products: onco, peptides, iron compounds
7/ Manufacturing Capacity & Capex

4 plants 762KL capacity, running at 85% capacity: 3 USFDA approved, 1 for emerging markets

Increasing capacity by 200KL in Dahej & Ankleshwar by FY23

Investing in a new greenfield capacity: will take it to aggregate 800KL capacity in 3-4yr
8/ Experienced Management with a proven track record: A total of 1537 permanent employees.
9/ CDMO business: 8-10% of their rev (will ramp up)

End of lifecycle management- when the innovator loses its patent & looks for a cheaper source of their API; they can choose GLS

The ๐ŸŒŽ trends that benefit this business ๐Ÿ‘‡
10/ Financials

Rev scaled at 16% cagr from FY19-21

Margins consistently above 30% (high operational efficiency as GMs are 50-55%)

Stable cash flows: WC requirements are high, OCF & debt would be enough to increase capacity over the next 4-5yrs
11/ Risks:

- High Customer churn: Only 41% of the customers stayed from FY19 to FY21.
- Imports 40% of RM from China: could face huge pricing pressure which they are not able to pass on.
- Regulatory & compliance risks
- Client concentration: 56% of rev from the top 5 customers
12/

- Dependence on key products: Top 10 account for 66% of sales
- Capex implementation risk
- Multiple outstanding litigations against the promoter & the company
- COVID risk: some disruptions in acute products & favipiravir sales benefit: net 2-3% +ve effect in FY21.
13/

- Increased competition in their respective products: pricing pressure
- Working capital risk: have huge credit terms up to 180 days
- High employee attrition of 18-20%
- Failure to get the environmental clearances for new facilities.
14/

We believe Glenmark Life sciences IPO which is currently valued at 4.6x EV/sales, 15x EV/EBITDA & 25x Price/Earnings & following the lucrative strategy to become bigger in complex APIs, is rather reasonably valued.

End of thread.
Comparison with the peers

- Top quartile EBITDA margins
- Low capex requirements & high asset turnover business
- Cash conversion cycle is one of the worst: Needs to invest a lot of working capital to grow if it doesn't improve
- Valuation wise, A discount to industry averages
A glossary for the complex industry-related abbreviations I used above ๐Ÿ‘‡
To understand more about the business dynamics of the API sector in depth

Watch this video by Sajal Sir @unseenvalue, hosted by @soicfinance (Better get the whole webinar from them)

โ€ข โ€ข โ€ข

Missing some Tweet in this thread? You can try to force a refresh
ใ€€

Keep Current with Anish Moonka

Anish Moonka Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @AnishA_Moonka

Nov 22, 2022
1/ Network Orchestration, A moat

The business model of PDS ๐Ÿ‘•๐Ÿ‘–

They play the role of the Orchestrator: A platform that connects to & finds synergies among 1000s of local networks across the world to create collective value for the network & its stakeholders

H/T @Chins1729 ๐Ÿ‘‘
Image
Image
2/ It's hard for a traditional firm to move towards being a Network Orchestrator

X | From thinking about their firm โ†’ The whole Network
Y | From Management control โ†’ Empowerment
Z | Shift in Value Creation through Specialisation โ†’ Integration

High Entry Barrier ๐Ÿšง Image
3/ X

Two retail stores in New York City may appear to be direct competitors, but this is an illusion.

Each store has a supply chain stretching from its shelves out to the world

Before a customer walks into the store, often the game is over based on the superior supply chain. Image
Read 8 tweets
Nov 19, 2022
There's this perception that IDFC First Bank has only one leader, Mr. V Vaidyanathan

Let me put rest to this mistaken opinion.

A thread ๐Ÿงต๐Ÿ‘‡
1/ Madhivanan Balakrishnan, COO

MSMEs need to be connected to digital entrepreneurs

Using E-marketplace, GEMS, & GST, bankers are augmenting the underwriting with these

70-75% of the retail lending 100% digital: 4-4.5 lk loans/month (digitally)

OCEN ๐Ÿš€
2/ Sumit Madan, Head- Retail Liabilities & Branch Banking

The only bank in the country with an integrated app: For CA & SA (Aids MSMEs)

The startup ecosystem is uniting all Indians

Among the highest rates for Debit cards & the lowest for credit cards
Read 8 tweets
Nov 17, 2022
IRFC: Business Analysis ๐Ÿš‚

A Regulated Monopoly Lender with zero NPAs & growing faster than HDFC & ICICI Banks

I authored this on Dec 2021 when the stock was barely talked about, posting it today to improve my engagement numbers on Twitter โœจ

A Thread ๐Ÿงต๐Ÿ‘‡
1/ History.

IRFC was established in 1986 as a dedicated market borrowing arm of the Indian Railways, registered with the RBI as an NBFC (Systematically Important)

But why do Railways need them, can't they directly ask for funds from the Ministry of Railways (MoR)?
2/ Here, enters the Government according to whom raising money from the open market is not the duty of MoR, it is the duty of the Ministry of Finance (MoF)

which didn't want to act as an intermediary & thus IRFC was born to raise money& fund the capital needs of Indian Railways.
Read 20 tweets
Nov 13, 2022
Real estate stocks have taken a tiny hit due to the interest rate hikes

Zoom Out. This is just a minor blip in this cycle

If the cycle goes the way it has in the past, most of the companies can become 5-10x larger in the next 5 years

If it doesn't, you still double your money. Image
1/ From Godrej Properties Q2FY23 concall

Price acceleration (across all markets) is driven by the end consumer & not just investors. Interesting. Image
2/ Continuing on the above... Mr. Godrej is quite bullish on the real estate cycle picking up in the next 4-5 years. That's why they are doing a lot of asset-heavy deals these days & did massive QIPs.

Later, we might see a downcycle again. Still, good times are probably near. Image
Read 8 tweets
Nov 13, 2022
Strong execution from Sunteck Realty: Targeting a 1800crs TTM Pre-sales by FY23 end.

- $ 3.8 billion (30K crores+) is Est. Gross Development Value (GDV) of the upcoming project pipeline in the next 7-8 years
- 37 million sq ft Across 7 projects

Very Interesting!
1/ They have nearly 2000 crores unsold inventory as of the date

They are also planning to launch 6000 crores worth of projects in the next 18 months

If the demand scenario stays robust, the targets above should not be hard to meet

Target: Double Pre-sales every 2-2.5 years ๐Ÿš€
2/ "Sunteck has grown in the last 15 years with all the headwinds in the industry. We have been able to grow at a time when most other players have not been able to survive." ~ Kamal Khetan, Chairman & MD.
Read 5 tweets
Nov 12, 2022
Sridhar Vembu Interview ๐Ÿ‘‘

1. R&D Spends >>> Marketing Spends (The opposite is unsustainable, the last year was a bubble)
2. They have always followed an organic process of building deep capabilities over time which allows them to build great products
3. They are investing in medical technology, EVs, Robotics, Network Equipments, AI & ML
4. Future of SaaS? The market is great, however, too many people are chasing it (We need a period of consolidation as no business wants to work with 10s of thousands of companies, only 5-10)
5. Microsoft is 200x our size, and Salesforce at 40x; those are the milestones we want to reach (Global Leadership)
6. What he needs in investments? I look for problems to be solved
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(